$AVRW
Avenir Wellness Solutions, Inc. Stock $avrw

$avrw Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000147793222008821 Filed on November 21, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue		$1.784M	$1.359M
YoY Change		31.27%	607.81%
Cost Of Revenue		$356.0K	$512.0K
YoY Change		-30.47%	253.1%
Gross Profit		$1.428M	$847.0K
YoY Change		68.6%	1702.13%
Gross Profit Margin		80.04%	62.33%
Selling, General & Admin		$3.612M	$4.584M
YoY Change		-21.2%	120.92%
% of Gross Profit		252.94%	541.2%
Research & Development			$601.0K
YoY Change			-19.22%
% of Gross Profit			70.96%
Depreciation & Amortization		$0.00	$1.006M
YoY Change		-100.0%	1043.18%
% of Gross Profit		0.0%	118.77%
Operating Expenses		$3.933M	$5.793M
YoY Change		-32.11%	105.5%
Operating Profit		-$2.506M	-$4.946M
YoY Change		-49.33%	78.43%
Interest Expense		$6.000K	-$176.0K
YoY Change		-103.41%	1157.14%
% of Operating Profit
Other Income/Expense, Net		-$403.0K	$603.0K
YoY Change		-166.83%	2771.43%
Pretax Income		-$2.909M	-$4.343M
YoY Change		-33.02%	57.87%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings		-$3.593M	-$4.343M
YoY Change		-17.27%	57.87%
Net Earnings / Revenue		-201.4%	-319.57%
Basic Earnings Per Share			-$0.07
Diluted Earnings Per Share		-$50.83K	-$0.07
COMMON SHARES
Basic Shares Outstanding	71.38M shares	71.14M shares	62.17M shares
Diluted Shares Outstanding			62.17M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$4.443M	$164.0K
YoY Change		2609.15%	-85.12%
Cash & Equivalents	$2.943M	$4.443M	$164.0K
Short-Term Investments
Other Short-Term Assets	$58.00K	$58.00K	$431.0K
YoY Change	-56.06%	-86.54%	12.83%
Inventory	$145.0K	$640.0K	$960.0K
Prepaid Expenses	$176.0K	$359.0K
Receivables	$232.0K	$460.0K	$208.0K
Other Receivables		$2.200M	$0.00
Total Short-Term Assets	$5.928M	$8.251M	$1.763M
YoY Change	232.85%	368.01%	-23.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.000K	$3.000K	$1.902M
YoY Change	-99.78%	-99.84%	-5.84%
Goodwill	$0.00	$4.690M	$13.87M
YoY Change	-100.0%	-66.18%
Intangibles	$244.0K	$248.0K	$15.03M
YoY Change	-98.34%	-98.35%
Long-Term Investments		$216.0K	$509.0K
YoY Change		-57.56%	0.0%
Other Assets		$71.00K	$83.00K
YoY Change		-14.46%	137.14%
Total Long-Term Assets	$926.0K	$6.713M	$40.12M
YoY Change	-97.61%	-83.27%	44.52%
TOTAL ASSETS
Total Short-Term Assets	$5.928M	$8.251M	$1.763M
Total Long-Term Assets	$926.0K	$6.713M	$40.12M
Total Assets	$6.854M	$14.96M	$41.88M
YoY Change	-83.11%	-64.27%	39.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.065M	$1.630M	$2.242M
YoY Change	-62.61%	-27.3%	25.67%
Accrued Expenses	$1.585M	$1.431M	$4.399M
YoY Change	-57.77%	-67.47%	1438.11%
Deferred Revenue
YoY Change
Short-Term Debt		$588.0K	$2.410M
YoY Change		-75.6%	-17.35%
Long-Term Debt Due		$9.984M	$8.036M
YoY Change		24.24%	66866.67%
Total Short-Term Liabilities	$13.91M	$15.06M	$17.70M
YoY Change	-42.65%	-14.93%	232.86%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$3.139M
YoY Change		-100.0%	7200.0%
Other Long-Term Liabilities		$81.00K	$2.457M
YoY Change		-96.7%	2896.34%
Total Long-Term Liabilities		$81.00K	$5.596M
YoY Change		-98.55%	4376.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.91M	$15.06M	$17.70M
Total Long-Term Liabilities		$81.00K	$5.596M
Total Liabilities	$13.96M	$15.14M	$23.29M
YoY Change	-42.94%	-35.02%	328.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$120.0M	-$112.8M	-$90.09M
YoY Change	27.01%	25.22%
Common Stock	$71.00K	$71.00K	$66.00K
YoY Change	2.9%	7.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.105M	-$173.0K	$18.59M
YoY Change
Total Liabilities & Shareholders Equity	$6.854M	$14.96M	$41.88M
YoY Change	-83.11%	-64.27%	39.29%

Cashflow Statement

Concept	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$3.593M	-$4.343M
YoY Change	-17.27%	57.87%
Depreciation, Depletion And Amortization	$0.00	$1.006M
YoY Change	-100.0%	1043.18%
Cash From Operating Activities	-$4.917M	-$2.000M
YoY Change	145.85%	47.93%
INVESTING ACTIVITIES
Capital Expenditures		-$1.000K
YoY Change		-98.31%
Acquisitions
YoY Change
Other Investing Activities	$13.89M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	$13.89M	-$1.000K
YoY Change	-1389200.0%	-99.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.582M	464.0K
YoY Change	-1087.5%	-71.6%
NET CHANGE
Cash From Operating Activities	-4.917M	-2.000M
Cash From Investing Activities	13.89M	-1.000K
Cash From Financing Activities	-4.582M	464.0K
Net Change In Cash	4.392M	-1.537M
YoY Change	-385.75%	370.03%
FREE CASH FLOW
Cash From Operating Activities	-$4.917M	-$2.000M
Capital Expenditures		-$1.000K
Free Cash Flow		-$1.999M
YoY Change		54.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71376799	shares
	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.26
	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.17
	dei	Entity Central Index Key EntityCentralIndexKey	0001643301
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71376799	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68201900	shares
CY2021	curr	Contract Liabilities Ending Balance ContractLiabilitiesEndingBalance	293	usd
	curr	Impairment Loss ImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q3	curr	Maximum Share Receivale Upon Achievement Of Certain Sales Milestones MaximumShareReceivaleUponAchievementOfCertainSalesMilestones	5988024	shares
CY2022Q3	curr	Asset Purchase Agreement Description AssetPurchaseAgreementDescription	total consideration paid at closing in the amount of $20.0 million, which consisted of (i) the cancellation of indebtedness owed by CURE to the Buyer in the amount of $4.15 million, (ii) a $2.0 million one-year note payable in the form of a secured promissory note, and (iii) the remainder in cash.
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2021Q3	curr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding And Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstandingAndExercisable	0	usd
	curr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding And Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstandingAndExercisable	0	usd
	curr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding And Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstandingAndExercisable	0	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	0	usd
	curr	Fair Value Of Contingent Share Consideration Assets Fair Value FairValueOfContingentShareConsiderationAssetsFairValue	143000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Registrant Name EntityRegistrantName	CURE PHARMACEUTICAL HOLDING CORP.
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-204857
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Trading Symbol TradingSymbol	CURR
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	37-1765151
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5805 Sepulveda Blvd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 801
	dei	Entity Address City Or Town EntityAddressCityOrTown	Sherman Oaks
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91411
	dei	City Area Code CityAreaCode	424
	dei	Local Phone Number LocalPhoneNumber	273-8675
	dei	Security12g Title Security12gTitle	Common stock, par value $0.001
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	71376799	shares
CY2022Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2022Q3	us-gaap	Grants Receivable Noncurrent GrantsReceivableNoncurrent	0	usd
CY2021Q4	us-gaap	Grants Receivable Noncurrent GrantsReceivableNoncurrent	200000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	4690000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	248000	usd
CY2022Q3	curr	Customer Relationships Trade Name And Non Compete Agreements Net CustomerRelationshipsTradeNameAndNonCompeteAgreementsNet	1299000	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	71000	usd
CY2022Q3	curr	Long Term Assets Held For Sale LongTermAssetsHeldForSale	0	usd
CY2022Q3	us-gaap	Assets Assets	14964000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1630000	usd
CY2022Q3	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	1431000	usd
CY2021Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	3485000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	118000	usd
CY2022Q3	us-gaap	Loans Payable Current LoansPayableCurrent	38000	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	2011000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2022Q3	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2022Q3	curr	Fair Value Convertible Promissory Notes Net FairValueConvertiblePromissoryNotesNet	9984000	usd
CY2022Q3	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	388000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	917000	usd
CY2022Q3	curr	Current Liabilities Held For Sale CurrentLiabilitiesHeldForSale	0	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	15056000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	81000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	174000	usd
CY2022Q3	curr	Long Term Liabilities Held For Sale LongTermLiabilitiesHeldForSale	0	usd
CY2022Q3	us-gaap	Liabilities Liabilities	15137000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68201900	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	71000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	112257000	usd
CY2022Q3	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	308000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-112809000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-173000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14964000	usd
CY2022Q3	us-gaap	Revenues Revenues	1784000	usd
CY2021Q3	us-gaap	Revenues Revenues	1350000	usd
	us-gaap	Revenues Revenues	3983000	usd
	us-gaap	Revenues Revenues	4679000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	356000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	436000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	843000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1469000	usd
	us-gaap	Gross Profit GrossProfit	3140000	usd
	us-gaap	Gross Profit GrossProfit	3210000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3612000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4216000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9481000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14182000	usd
CY2022Q3	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	322000	usd
CY2021Q3	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	608000	usd
	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	-513000	usd
	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	-947000	usd
CY2022Q3	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	usd
CY2021Q3	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	usd
	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	4622000	usd
	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	3933000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	4824000	usd
	us-gaap	Operating Expenses OperatingExpenses	13590000	usd
	us-gaap	Operating Expenses OperatingExpenses	13235000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2506000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3910000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10450000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10025000	usd
CY2022Q3	us-gaap	Interest Income Operating InterestIncomeOperating	14000	usd
CY2021Q3	us-gaap	Interest Income Operating InterestIncomeOperating	2000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	17000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	4000	usd
CY2022Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
CY2021Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	82000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	2434000	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	7000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	40000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	741000	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2021Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-41000	usd
CY2022Q3	curr	Change In Fair Value Of Convertible Promissory Notes ChangeInFairValueOfConvertiblePromissoryNotes	-411000	usd
CY2021Q3	curr	Change In Fair Value Of Convertible Promissory Notes ChangeInFairValueOfConvertiblePromissoryNotes	772000	usd
	curr	Change In Fair Value Of Convertible Promissory Notes ChangeInFairValueOfConvertiblePromissoryNotes	-718000	usd
	curr	Change In Fair Value Of Convertible Promissory Notes ChangeInFairValueOfConvertiblePromissoryNotes	1112000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	6000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	178000	usd
	us-gaap	Interest Expense InterestExpense	393000	usd
	us-gaap	Interest Expense InterestExpense	377000	usd
CY2022Q3	us-gaap	Other Income OtherIncome	0	usd
CY2021Q3	us-gaap	Other Income OtherIncome	0	usd
	us-gaap	Other Income OtherIncome	26000	usd
	us-gaap	Other Income OtherIncome	0	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-403000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	603000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-946000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3873000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2909000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3307000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11396000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6152000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2909000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3307000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11396000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6152000	usd
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-119000	usd
CY2021Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-1036000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-6402000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-2683000	usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-565000	usd
CY2021Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-565000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2022Q3	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	0	usd
CY2021Q3	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	0	usd
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	0	usd
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	0	usd
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-684000	usd
CY2021Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-1036000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-6967000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-2683000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3593000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4343000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18363000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8835000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.04
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.05
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.16
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
CY2022Q3	curr	Disposal Group DisposalGroup	-0.01
CY2021Q3	curr	Disposal Group DisposalGroup	-0.02
	curr	Disposal Group DisposalGroup	-0.10
	curr	Disposal Group DisposalGroup	-0.05
CY2022Q3	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.05
CY2021Q3	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.07
CY2022Q3	curr	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	70686677	shares
CY2021Q3	curr	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	62174822	shares
	curr	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	69808785	shares
	curr	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	49294190	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16112000	usd
CY2022Q1	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	17000	usd
CY2022Q1	curr	Issuance Of Common Stock From Conversion Of Convertible Promissory Notes Amount IssuanceOfCommonStockFromConversionOfConvertiblePromissoryNotesAmount	666000	usd
CY2022Q1	curr	Fair Value Of Stock Options And Restricted Stock Granted FairValueOfStockOptionsAndRestrictedStockGranted	352000	usd
CY2022Q1	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	103000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5151000	usd
CY2022Q2	curr	Fair Value Of Stock Options And Restricted Stock Granted FairValueOfStockOptionsAndRestrictedStockGranted	316000	usd
CY2022Q2	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	102000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-9619000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2888000	usd
CY2022Q3	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	241000	usd
CY2022Q3	curr	Fair Value Of Stock Options And Restricted Stock Granted FairValueOfStockOptionsAndRestrictedStockGranted	189000	usd
CY2022Q3	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	102000	usd
CY2022Q3	curr	Issuance Of Restricted Stock Units Amount IssuanceOfRestrictedStockUnitsAmount	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3593000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-173000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	21279000	usd
CY2021Q1	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	508000	usd
CY2021Q1	curr	Issuance Of Common Stock From The Equity Incentive Plan Amount IssuanceOfCommonStockFromTheEquityIncentivePlanAmount	138000	usd
CY2021Q1	curr	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	0	usd
CY2021Q1	curr	Fair Value Of Stock Options And Restricted Stock Granted FairValueOfStockOptionsAndRestrictedStockGranted	961000	usd
CY2021Q1	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	144000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-3171000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	19859000	usd
CY2021Q2	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	243000	usd
CY2021Q2	curr	Issuance Of Common Stock From The Equity Incentive Plan Amount IssuanceOfCommonStockFromTheEquityIncentivePlanAmount	-157000	usd
CY2021Q2	curr	Issuance Of Common Stock From Conversion Of Convertible Promissory Notes Amount IssuanceOfCommonStockFromConversionOfConvertiblePromissoryNotesAmount	1835000	usd
CY2021Q2	curr	Fair Value Of Stock Options And Restricted Stock Granted FairValueOfStockOptionsAndRestrictedStockGranted	591000	usd
CY2021Q2	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	143000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1321000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	21193000	usd
CY2021Q3	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	0	usd
CY2021Q3	curr	Issuance Of Common Stock From Conversion Of Convertible Promissory Notes Amount IssuanceOfCommonStockFromConversionOfConvertiblePromissoryNotesAmount	1047000	usd
CY2021Q3	curr	Fair Value Of Stock Options And Restricted Stock Granted FairValueOfStockOptionsAndRestrictedStockGranted	532000	usd
CY2021Q3	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	156000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4343000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	18585000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11396000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6152000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-6967000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2683000	usd
	us-gaap	Profit Loss ProfitLoss	-18363000	usd
	us-gaap	Profit Loss ProfitLoss	-8835000	usd
	curr	Loss On Disposal Of Pharmaceutical Assets And Liabilities LossOnDisposalOfPharmaceuticalAssetsAndLiabilities	565000	usd
	curr	Loss On Disposal Of Pharmaceutical Assets And Liabilities LossOnDisposalOfPharmaceuticalAssetsAndLiabilities	0	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	7000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	176000	usd
	curr	Fair Value Of Vested Stock Options And Restricted Stock FairValueOfVestedStockOptionsAndRestrictedStock	-1405000	usd
	curr	Fair Value Of Vested Stock Options And Restricted Stock FairValueOfVestedStockOptionsAndRestrictedStock	-2527000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	68000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	127000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	529000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	61000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-952000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	104000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	25000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1178000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	107000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2012000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3302000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-79000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-68000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	95000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-598000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-5112000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	752000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19000	usd
	curr	Gain From Extinguishment Of Debt GainFromExtinguishmentOfDebt	40000	usd
	curr	Gain From Extinguishment Of Debt GainFromExtinguishmentOfDebt	735000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	513000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	947000	usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-718000	usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	1111000	usd
	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	4622000	usd
	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1390000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1741000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	71000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	63000	usd
	curr	Bad Debt Expense BadDebtExpense	0	usd
	curr	Bad Debt Expense BadDebtExpense	6000	usd
	us-gaap	Recovery Of Direct Costs RecoveryOfDirectCosts	35000	usd
	us-gaap	Recovery Of Direct Costs RecoveryOfDirectCosts	221000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	108000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-795000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8487000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2657000	usd
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	13891000	usd
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0	usd
	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	0	usd
	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	99000	usd
	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	0	usd
	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	200000	usd
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	0	usd
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	200000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13891000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-99000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	252000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1000000	usd
	curr	Proceeds From Notes Payable Of Disposal Group ProceedsFromNotesPayableOfDisposalGroup	4150000	usd
	curr	Proceeds From Notes Payable Of Disposal Group ProceedsFromNotesPayableOfDisposalGroup	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1561000	usd
CY2022Q3	curr	Working Capital Deficit WorkingCapitalDeficit	6600000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1725000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4443000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3129000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	190000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	400000	usd
	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	2243000	usd
	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	0	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	38000	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	0	usd
	us-gaap	Repayments Of Commercial Paper RepaymentsOfCommercialPaper	235000	usd
	us-gaap	Repayments Of Commercial Paper RepaymentsOfCommercialPaper	205000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-977000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1195000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4427000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	164000	usd
	us-gaap	Interest Paid Net InterestPaidNet	585000	usd
	us-gaap	Interest Paid Net InterestPaidNet	102000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	curr	Cancellation Of Indebtedness To Buyer Of Assets Sold Non Cash Item CancellationOfIndebtednessToBuyerOfAssetsSoldNonCashItem	-4150000	usd
	curr	Cancellation Of Indebtedness To Buyer Of Assets Sold Non Cash Item CancellationOfIndebtednessToBuyerOfAssetsSoldNonCashItem	0	usd
	curr	Other Significant Noncash Transactions Consideration Received OtherSignificantNoncashTransactionsConsiderationReceived	-2000000	usd
	curr	Other Significant Noncash Transactions Consideration Received OtherSignificantNoncashTransactionsConsiderationReceived	0	usd
CY2022Q3	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	-112800000	usd
	curr	Common Stock Issued For Conversion Of Promissory Notes And Accrued Interest CommonStockIssuedForConversionOfPromissoryNotesAndAccruedInterest	666000	usd
	curr	Common Stock Issued For Conversion Of Promissory Notes And Accrued Interest CommonStockIssuedForConversionOfPromissoryNotesAndAccruedInterest	2881000	usd
	curr	Reclassification Of Accrued Expense To Related Party Payable ReclassificationOfAccruedExpenseToRelatedPartyPayable	42000	usd
	curr	Reclassification Of Accrued Expense To Related Party Payable ReclassificationOfAccruedExpenseToRelatedPartyPayable	0	usd
	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s financial statements. Such financial statements and accompanying notes are the representations of Company’s management, who is responsible for their integrity and objectivity.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of September 30, 2022, and the results of operations and cash flows for the periods presented. The results of operations for the three and nine months ended September 30, 2022 and 2021, are not necessarily indicative of the operating results for the full fiscal year or any future period, given the recent completion of the Asset Sale. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed with the SEC on April 1, 2022 (our “2021 Annual Report”).</p>
CY2022Q3	us-gaap	Cash Cash	4400000	usd
	us-gaap	Reclassifications Reclassifications	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Certain reclassifications have been made to prior year’s consolidated financial statements to enhance comparability with the current year’s consolidated financial statements. These reclassifications had no effect on the previously reported net loss.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, authoritative accounting pronouncements, and other factors that management believes to be reasonable. In addition, the Company has considered the potential impact of the COVID-19 pandemic, as well as certain macroeconomic factors, including inflation, rising interest rates, and recessionary pressures, on its business and operations. Although the full impact of these factors are unknown and cannot be reasonably estimated, the Company believes it has made appropriate accounting estimates and assumptions based on the facts and circumstances available as of the reporting date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant areas requiring the use of management estimates include, but are not limited to, revenue recognition, the allowance for doubtful accounts, valuation of intangible assets and goodwill, depreciative and amortization useful lives, assumptions used to calculate the fair value of the contingent share consideration, stock based compensation, beneficial conversion features, warrant values, deferred taxes and the assumptions used to calculate derivative liabilities and fair values of the purchase price allocations and convertible promissory notes. Actual results could differ materially from such estimates under different assumptions or circumstances.</p>
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q3	curr	Excess Im Fdic Insured Amount ExcessImFdicInsuredAmount	4000000.0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1000	usd
	curr	Contract Liabilitiespolicytextblcok ContractLiabilitiespolicytextblcok	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Advance payments and billings in excess of revenue recognized represent contract liabilities and are recorded as deferred revenue when customers remit contractual cash payments in advance before satisfying performance obligations under contractual arrangements. Contract liabilities are derecognized when revenue is recognized, and the performance obligation is satisfied. Advance payments and billings in excess of revenue recognized are included in deferred revenue, which is classified as current or noncurrent based on the timing of when the Company expects to recognize revenue. At September 30, 2022 and December 31, 2021, we had contract liabilities of $0.4 million and $0.3 million, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Contract liabilities is made up of the following as of September 30, 2022 and December 31, 2021 (in thousands):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Customer deposits for commercial products</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">388</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">293</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following table summarizes the changes in contract liabilities during the nine months ended September 30, 2022 and year ended December 31, 2021 (in thousands):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">994</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">435</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Customer deposits returned</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(713 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Transfers to revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(208 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Contract liabilities held for sale</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(215 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">293</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">26</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Customer deposits returned</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(45 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Transfers to revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(84 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Contract liabilities held for sale but not assumed </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">198</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at September 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">388</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	400000	usd
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2000000.0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4700000	usd
CY2021Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q3	curr	Impairment Loss ImpairmentLoss	0	usd
	curr	Impairment Loss ImpairmentLoss	4600000	usd
CY2021Q3	curr	Impairment Loss ImpairmentLoss	0	usd
	curr	Contingent Consideration Liabilitiespolicytextblock ContingentConsiderationLiabilitiespolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Certain of the Company’s business acquisitions involve the potential for future payment of consideration to former selling stockholders in amounts determined upon the attainment of revenue and gross margin milestones from product sales. The fair value of such liabilities is determined using unobservable inputs. These inputs include the estimated amount and timing of projected cash flows and the risk-adjusted discount rate used to present value the cash flows. These obligations are referred to as contingent consideration.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">ASC 805, “Business Combinations,” requires that contingent consideration be estimated and recorded at fair value as of the acquisition date as part of the total consideration transferred. Contingent consideration is an obligation of the acquirer to transfer additional assets or equity interests to the selling stockholders in the future if certain future events occur or conditions are met, such as: (i) the attainment of product development milestones; and/or (ii) the achievement of components of earnings, such as “earn-out” provisions or percentage of future revenue.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The fair value of contingent consideration after the acquisition date is reassessed by the Company as changes in circumstances and conditions occur, with the subsequent change in fair value recorded in the consolidated statements of operations. Changes in key assumptions can materially affect the estimated fair value of contingent consideration liabilities and, accordingly, the resulting gain or loss is recorded in its unaudited condensed consolidated financial statements. See Note 19 – Business Combination for additional information.</p>
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	300000	usd
CY2022Q3	curr	Customer Deposits Current Commercial Products CustomerDepositsCurrentCommercialProducts	388000	usd
CY2021Q4	curr	Customer Deposits Current Commercial Products CustomerDepositsCurrentCommercialProducts	293000	usd
	curr	Sera Labs Revenuepolicytexkblock SeraLabsRevenuepolicytexkblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Sera Labs recognizes revenue as, or when, we satisfy performance obligations under a contract. We account for a contract when the parties approved the contract and are committed to perform on it, the rights of each party and the payment terms are identified, the contract has commercial substance and it is probable that we will collect substantially all of the consideration. A performance obligation is a promise in a contract to transfer a distinct good or service, or a series of distinct goods or services, to a customer. The transaction price of a contract must be allocated to each performance obligation and recognized as the performance obligation is satisfied. In essence, we recognize revenue when or as control of the promised goods or services transfer to the customer.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.35pt; TEXT-INDENT: 33.75pt; text-align:justify;">Revenue from eCommerce sales, including DTC sales, are recognized upon delivery of merchandise to the customer. We also elected to adopt the practical expedient related to shipping and handling fees which allows us to account for shipping and handling activities that occur after control of the related good transfers as fulfillment activities instead of assessing such activities as performance obligations. Therefore, shipping and handling activities are considered part of the Company’s obligation to transfer the products and therefore are recorded as direct selling expenses, as incurred. Shipping revenue is recorded upon delivery to the customer.</p>
	curr	Practical Expedients And Exemptionspolicytextblock PracticalExpedientsAndExemptionspolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Company has elected certain practical expedients and policy elections as permitted under ASC Topic 606 as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the Company adopted the practical expedient related to not adjusting the promised amount of consideration for the effects of a significant financing component if the period between transfer of product and customer payment is expected to be less than one year at the time of contract inception;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the Company made the accounting policy election to exclude any sales and similar taxes from the transaction price; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the Company adopted the practical expedient not to disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.</p></td></tr></tbody></table>
	curr	Sales Taxpolicytextblock SalesTaxpolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised goods or services to a customer, excluding sales taxes. The net amount of sales tax payable to the taxation authority is included sales tax payable in the unaudited condensed consolidated balance sheets.</p>
	curr	Sales Returns Discounts And Warrantiespolicytextblock SalesReturnsDiscountsAndWarrantiespolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Sales returns, discount and warranties are considered variable consideration under ASC 606. The Company reduces revenue for estimated future returns, discounts and warranties which may occur with distributors and retailers. When evaluating the adequacy of sales returns, discounts and warranties, the Company analyzes the following: historical credit allowances, current sell-through of inventory of the Company’s products, current trends in retail industry, changes in customer demand, acceptance of products, and other related factors.</p>
	curr	Cost To Obtain A Contractpolicytextblock CostToObtainAContractpolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Company pays sales commission to its employees and outside sales representatives for contracts that they obtain relating to the wholesale sales of our products. The Company applies the optional practical expedient to immediately expense costs to obtain a contract if the amortization period of the asset that would have been recognized is one year or less. As such, sales commissions are immediately recognized as an expense and included as part of sales and marketing expenses.</p>
CY2021	curr	Contract Liabilities Beginning Balance ContractLiabilitiesBeginningBalance	994000	usd
CY2021	curr	Additions To Contract Liabilities AdditionsToContractLiabilities	435000	usd
CY2021	curr	Contract Liabilities Customer Deposits Returned ContractLiabilitiesCustomerDepositsReturned	-713000	usd
CY2021	curr	Contract Liabilities Transfers To Revenue ContractLiabilitiesTransfersToRevenue	-208000	usd
CY2021	curr	Contract Liabilities Asset For Sale Value ContractLiabilitiesAssetForSaleValue	-215000	usd
	curr	Contract Liabilities Beginning Balance ContractLiabilitiesBeginningBalance	293000	usd
	curr	Additions To Contract Liabilities AdditionsToContractLiabilities	26000	usd
	curr	Contract Liabilities Customer Deposits Returned ContractLiabilitiesCustomerDepositsReturned	-45000	usd
	curr	Contract Liabilities Transfers To Revenue ContractLiabilitiesTransfersToRevenue	-84000	usd
	curr	Contract Liabilities Not Assumed Amount ContractLiabilitiesNotAssumedAmount	198000	usd
	curr	Contract Liabilities Ending Balance ContractLiabilitiesEndingBalance	388000	usd
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	700000	usd
	us-gaap	Advertising Expense AdvertisingExpense	1400000	usd
CY2021Q3	us-gaap	Advertising Expense AdvertisingExpense	700000	usd
	us-gaap	Advertising Expense AdvertisingExpense	2200000	usd
CY2022Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	30000.00	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	500000	usd
CY2021Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	600000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1900000	usd
CY2022Q3	curr	Valuation Allowance Percentage ValuationAllowancePercentage	1	pure
	curr	Clawback Expected Gross Profit ClawbackExpectedGrossProfit	8000000.0	usd
	curr	Changes In Fair Value Of Series A Note ChangesInFairValueOfSeriesANote	61000	usd
	curr	Change In Fair Value Of Series B Notes ChangeInFairValueOfSeriesBNotes	657000	usd
	curr	Conversion Of Series B Notes ConversionOfSeriesBNotes	-666000	usd
CY2022Q3	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	9984	usd
CY2022Q3	curr	Fair Value Of Contingent Stock Consideration FairValueOfContingentStockConsideration	917000	usd
CY2022Q3	curr	Fair Value Of Series A Note FairValueOfSeriesANote	3136000	usd
CY2022Q3	curr	Fair Value Of Series B Note FairValueOfSeriesBNote	6848000	usd
CY2021Q4	curr	Fair Value Of Contingent Stock Consideration FairValueOfContingentStockConsideration	1430000	usd
CY2021Q4	curr	Fair Value Of Series A Note FairValueOfSeriesANote	3075000	usd
CY2021Q4	curr	Fair Value Of Series B Note FairValueOfSeriesBNote	6857000	usd
CY2021Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	9932000	usd
	curr	Stock Price StockPrice	0.26
CY2021	curr	Stock Price StockPrice	0.36
	curr	Conversion Price ConversionPrice	1.32
CY2021	curr	Conversion Price ConversionPrice	1.32
	curr	Interest Rate InterestRate	0.18	pure
CY2021	curr	Interest Rate InterestRate	0.18	pure
CY2022Q3	curr	Gain Loss From Change In Fair Value Of Series A And B Convertible Notes GainLossFromChangeInFairValueOfSeriesAAndBConvertibleNotes	400000	usd
	curr	Gain Loss From Change In Fair Value Of Series A And B Convertible Notes GainLossFromChangeInFairValueOfSeriesAAndBConvertibleNotes	700000	usd
CY2021Q3	curr	Gain Loss From Change In Fair Value Of Series A And B Convertible Notes GainLossFromChangeInFairValueOfSeriesAAndBConvertibleNotes	800000	usd
	curr	Gain Loss From Change In Fair Value Of Series A And B Convertible Notes GainLossFromChangeInFairValueOfSeriesAAndBConvertibleNotes	1100000	usd
	curr	Vested Stock Options From The Companys Equity Incentive Plan VestedStockOptionsFromTheCompanysEquityIncentivePlan	3173469	shares
	curr	Vested Stock Options From The Companys Equity Incentive Plan VestedStockOptionsFromTheCompanysEquityIncentivePlan	3845124	shares
	curr	Contingencies Contingencies	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 35.3pt; text-align:justify;">We are exposed to claims and litigation arising in the ordinary course of business and use various methods to resolve these matters in a manner that we believe serves the best interest of our stockholders and other constituents. When a loss is probable, we record an accrual based on the reasonably estimable loss or range of loss. When no point of loss is more likely than another, we record the lowest amount in the estimated range of loss and, if material, disclose the estimated range of loss. We do not record liabilities for reasonably possible loss contingencies, but do disclose a range of reasonably possible losses if they are material and we are able to estimate such a range. If we cannot provide a range of reasonably possible losses, we explain the factors that prevent us from determining such a range. Historically, adjustments to our estimates have not been material. We believe the recorded reserves in our unaudited condensed consolidated financial statements are adequate in light of the probable and estimable liabilities. We do not believe that any of these identified claims or litigation will be material to our results of operations, cash flows, or financial condition. Gain contingencies are recorded when the ultimate resolution of the contingency is resolved. </p>
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2909000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3307000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11396000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6152000	usd
CY2022Q3	curr	Loss From Disposal Group LossFromDisposalGroup	-684000	usd
CY2021Q3	curr	Loss From Disposal Group LossFromDisposalGroup	-1036000	usd
	curr	Loss From Disposal Group LossFromDisposalGroup	-6967000	usd
	curr	Loss From Disposal Group LossFromDisposalGroup	-2683000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3593000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-4343000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-18363000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-8835000	usd
CY2022Q3	curr	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	70686677	shares
CY2021Q3	curr	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	62174822	shares
	curr	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	69808785	shares
	curr	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	49294190	shares
CY2022Q3	curr	Common Stock And Common Stock Equivalents CommonStockAndCommonStockEquivalents	70686677	shares
CY2021Q3	curr	Common Stock And Common Stock Equivalents CommonStockAndCommonStockEquivalents	62174822	shares
	curr	Common Stock And Common Stock Equivalents CommonStockAndCommonStockEquivalents	69808785	shares
	curr	Common Stock And Common Stock Equivalents CommonStockAndCommonStockEquivalents	49294190	shares
CY2022Q3	curr	Continuing Operations Per Share ContinuingOperationsPerShare	-0.04
	curr	Continuing Operations Per Share ContinuingOperationsPerShare	-0.05
CY2021Q3	curr	Continuing Operations Per Share ContinuingOperationsPerShare	-0.16
	curr	Continuing Operations Per Share ContinuingOperationsPerShare	-0.12
CY2022Q3	curr	Disposal Group Per Share DisposalGroupPerShare	-0.01
	curr	Disposal Group Per Share DisposalGroupPerShare	-0.02
CY2021Q3	curr	Disposal Group Per Share DisposalGroupPerShare	-0.10
	curr	Disposal Group Per Share DisposalGroupPerShare	-0.05
	curr	Warrants Shares WarrantsShares	615530	shares
	curr	Warrants Shares WarrantsShares	1565447	shares
	curr	Shares To Be Issued Upon Conversion Of Convertible Payable SharesToBeIssuedUponConversionOfConvertiblePayable	115047	shares
	curr	Shares To Be Issued Upon Conversion Of Convertible Payable SharesToBeIssuedUponConversionOfConvertiblePayable	115047	shares
	curr	Anti Dilutive Shares AntiDilutiveShares	3904046	shares
	curr	Anti Dilutive Shares AntiDilutiveShares	5525618	shares
	curr	Common Stock Conversion Price CommonStockConversionPrice	1.32
CY2022Q3	curr	Customer Billed Accounts Receivable CustomerBilledAccountsReceivable	460000	usd
CY2021Q4	curr	Customer Billed Accounts Receivable CustomerBilledAccountsReceivable	437000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	80000	usd
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	460000	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	357000	usd
CY2022Q3	us-gaap	Prepaid Insurance PrepaidInsurance	91000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	302000	usd
CY2022Q3	curr	Prepaid Deposit For Inventory PrepaidDepositForInventory	0	usd
CY2021Q4	curr	Prepaid Deposit For Inventory PrepaidDepositForInventory	89000	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	359000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	58000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	46000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	508000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	447000	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	750000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	730000	usd
CY2022Q3	us-gaap	Inventory Adjustments InventoryAdjustments	-110000	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	-109000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	640000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	621000	usd
CY2022Q3	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	102000	usd
CY2021Q3	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	173000	usd
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	108000	usd
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	176000	usd
	curr	Consideration To Be Received From The Buyer ConsiderationToBeReceivedFromTheBuyer	20000000.0	usd
CY2022Q3	curr	Cancellation Of Indebtedness Owed By The Company To Buyer In Amount Equal CancellationOfIndebtednessOwedByTheCompanyToBuyerInAmountEqual	4150000	usd
CY2022Q3	curr	Cash Reduced By Assumed Liabilities CashReducedByAssumedLiabilities	41000	usd
CY2022Q3	curr	Retained Other Patents Not Included In The Asset Sale RetainedOtherPatentsNotIncludedInTheAssetSale	15	integer
CY2022Q3	curr	Net Cash Received From The Asset Sales Price NetCashReceivedFromTheAssetSalesPrice	20000000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Forgiveness Of Buyer Advances NetCashReceivedFromTheAssetSalesForgivenessOfBuyerAdvances	-4150000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Holdback Secured Promissory Note NetCashReceivedFromTheAssetSalesHoldbackSecuredPromissoryNote	-2000000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Obligations Assumed By Buyer NetCashReceivedFromTheAssetSalesObligationsAssumedByBuyer	-41000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Buyers Expense To Be Paid By Seller NetCashReceivedFromTheAssetSalesBuyersExpenseToBePaidBySeller	82000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales NetCashReceivedFromTheAssetSales	13891000	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	4000000.0	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities	3400000	usd
CY2022Q3	curr	Consideration Paid For Asset Sale ConsiderationPaidForAssetSale	20000000.0	usd
CY2022Q3	curr	Sales Price For Assets Sold SalesPriceForAssetsSold	20000000	usd
CY2022Q3	curr	Net Book Value Of Assets Sold NetBookValueOfAssetsSold	20616000	usd
CY2022Q3	curr	Net Book Value Of Liabilities Sold NetBookValueOfLiabilitiesSold	-51000	usd
CY2022Q3	curr	Net Book Value Of Net Assets Sold NetBookValueOfNetAssetsSold	20565000	usd
CY2022Q3	curr	Gain Loss On Sale Of Net Assets GainLossOnSaleOfNetAssets	-565000	usd
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	20600000	usd
	curr	Additional Impairment Loss AdditionalImpairmentLoss	2000000.0	usd
CY2022Q2	curr	Estimated Costs To Sell Charged To Goodwill EstimatedCostsToSellChargedToGoodwill	100000	usd
CY2021Q4	curr	Inventory Net Assets Held For Sale InventoryNetAssetsHeldForSale	243000	usd
CY2021Q4	curr	Prepaid Expense And Other Assets Current Assets Held For Sale PrepaidExpenseAndOtherAssetsCurrentAssetsHeldForSale	97000	usd
CY2021Q4	curr	Property Plant And Equipment Net Assets Held For Sale PropertyPlantAndEquipmentNetAssetsHeldForSale	1837000	usd
CY2021Q4	curr	Finance Lease Right Of Use Asset Assets Held For Sale FinanceLeaseRightOfUseAssetAssetsHeldForSale	40000	usd
CY2021Q4	curr	Goodwill Assets Held For Sale GoodwillAssetsHeldForSale	9178000	usd
CY2021Q4	curr	Intangible Assets Net Excluding Goodwill Assets Held For Sale IntangibleAssetsNetExcludingGoodwillAssetsHeldForSale	14401000	usd
CY2021Q4	curr	In Process Research And Development Net InProcessResearchAndDevelopmentNet	329000	usd
CY2021Q4	curr	Other Assets Assets Held For Sale OtherAssetsAssetsHeldForSale	35000	usd
CY2021Q4	curr	Total Assets Classified As Assets Held For Sale In The Consolidated Balance Sheet TotalAssetsClassifiedAsAssetsHeldForSaleInTheConsolidatedBalanceSheet	26160000	usd
CY2021Q4	curr	Accrued Utilities Current Assets Held For Sale AccruedUtilitiesCurrentAssetsHeldForSale	268000	usd
CY2021Q4	curr	Finance Lease Liability Current Assets Held For Sale FinanceLeaseLiabilityCurrentAssetsHeldForSale	40000	usd
CY2021Q4	curr	Deposit Contracts Liabilities Assets Held For Sale DepositContractsLiabilitiesAssetsHeldForSale	215000	usd
CY2021Q4	curr	Total Liabilities Classified As Liabilities Held For Sale In The Consolidated Balance Sheet TotalLiabilitiesClassifiedAsLiabilitiesHeldForSaleInTheConsolidatedBalanceSheet	523000	usd
CY2022Q3	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	0	usd
CY2021Q3	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	16000	usd
	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	108000	usd
	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	151000	usd
CY2022Q3	curr	Consulting Research Development Income Assets Held For Sale ConsultingResearchDevelopmentIncomeAssetsHeldForSale	0	usd
CY2021Q3	curr	Consulting Research Development Income Assets Held For Sale ConsultingResearchDevelopmentIncomeAssetsHeldForSale	0	usd
	curr	Consulting Research Development Income Assets Held For Sale ConsultingResearchDevelopmentIncomeAssetsHeldForSale	58000	usd
	curr	Consulting Research Development Income Assets Held For Sale ConsultingResearchDevelopmentIncomeAssetsHeldForSale	52000	usd
CY2022Q3	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	0	usd
CY2021Q3	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	18000	usd
	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	40000	usd
	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	57000	usd
CY2022Q3	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	0	usd
CY2021Q3	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	34000	usd
	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	206000	usd
CY2022Q3	us-gaap	Sale Leaseback Transaction Accumulated Depreciation SaleLeasebackTransactionAccumulatedDepreciation	4000	usd
	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	260000	usd
CY2022Q3	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	0	usd
CY2021Q3	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	75000	usd
	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	75000	usd
	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	256000	usd
CY2022Q3	curr	Gross Profit Loss GrossProfitLoss	0	usd
CY2021Q3	curr	Gross Profit Loss GrossProfitLoss	-41000	usd
	curr	Gross Profit Loss GrossProfitLoss	131000	usd
	curr	Gross Profit Loss GrossProfitLoss	4000	usd
CY2022Q3	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	28000	usd
CY2021Q3	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	601000	usd
	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	492000	usd
CY2021Q4	us-gaap	Sale Leaseback Transaction Accumulated Depreciation SaleLeasebackTransactionAccumulatedDepreciation	3000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	0	usd
	us-gaap	Depreciation Depreciation	1000.000	usd
CY2021Q3	us-gaap	Depreciation Depreciation	0	usd
	us-gaap	Depreciation Depreciation	1000.000	usd
CY2021Q4	us-gaap	Convertible Subordinated Debt ConvertibleSubordinatedDebt	11858000	usd
	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	1944000	usd
CY2022Q3	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	91000	usd
CY2021Q3	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	394000	usd
	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	1313000	usd
	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	743000	usd
	curr	Loss On Disposition Assets Held For Sale LossOnDispositionAssetsHeldForSale	565	usd
CY2021Q3	curr	Loss On Disposition Assets Held For Sale LossOnDispositionAssetsHeldForSale	0	usd
CY2022Q3	curr	Loss On Disposition Assets Held For Sale LossOnDispositionAssetsHeldForSale	565	usd
	curr	Loss On Disposition Assets Held For Sale LossOnDispositionAssetsHeldForSale	0	usd
CY2022Q3	curr	Impairment Of Goodwill Assets Held For Sale ImpairmentOfGoodwillAssetsHeldForSale	0	usd
CY2021Q3	curr	Impairment Of Goodwill Assets Held For Sale ImpairmentOfGoodwillAssetsHeldForSale	0	usd
	curr	Impairment Of Goodwill Assets Held For Sale ImpairmentOfGoodwillAssetsHeldForSale	4728000	usd
	curr	Impairment Of Goodwill Assets Held For Sale ImpairmentOfGoodwillAssetsHeldForSale	0	usd
CY2022Q3	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	684000	usd
CY2021Q3	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	995000	usd
	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	6533000	usd
	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	2687000	usd
CY2022Q3	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	-684000	usd
CY2021Q3	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	-1036000	usd
	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	-6967000	usd
	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	-2683000	usd
CY2022Q3	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
CY2021Q3	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
CY2022Q3	curr	Net Loss NetLoss	-684000	usd
CY2021Q3	curr	Net Loss NetLoss	-1036000	usd
	curr	Net Loss NetLoss	-6402000	usd
	curr	Net Loss NetLoss	-2683000	usd
CY2022Q3	us-gaap	Commercial Paper CommercialPaper	14984000	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	1000000.0	usd
CY2020	curr	Remaining Balance Of Investor Note Amount RemainingBalanceOfInvestorNoteAmount	5000000.0	usd
CY2020	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.08	pure
CY2022Q3	curr	Allowance For Doubtful Accounts Receivable1 AllowanceForDoubtfulAccountsReceivable1	0	usd
CY2021Q4	curr	Allowance For Doubtful Accounts Receivable1 AllowanceForDoubtfulAccountsReceivable1	0	usd
CY2022Q3	curr	Current Portion Of Note Receivable CurrentPortionOfNoteReceivable	-2200000	usd
CY2021Q4	curr	Current Portion Of Note Receivable CurrentPortionOfNoteReceivable	0	usd
CY2022Q3	curr	Notes Receivable Net Of Current Portion NotesReceivableNetOfCurrentPortion	0	usd
CY2021Q4	curr	Notes Receivable Net Of Current Portion NotesReceivableNetOfCurrentPortion	200000	usd
CY2022Q3	us-gaap	Goodwill Gross GoodwillGross	4690000	usd
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	4690000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3075000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10182000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1776000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2885000	usd
CY2022Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2021Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q3	us-gaap	Exploration Expense ExplorationExpense	200000	usd
CY2021Q3	us-gaap	Exploration Expense ExplorationExpense	600000	usd
	us-gaap	Exploration Expense ExplorationExpense	1400000	usd
	us-gaap	Exploration Expense ExplorationExpense	1700000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	169000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	675000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	512000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	23000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	18000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	17000	usd
CY2022Q3	curr	Finite Lived Intangible Assets Amortization Expense Rolling Thereafter FiniteLivedIntangibleAssetsAmortizationExpenseRollingThereafter	133000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1547000	usd
CY2021Q4	us-gaap	Commercial Paper CommercialPaper	14932000	usd
CY2022Q3	curr	Less Investor Note Offset LessInvestorNoteOffset	-5000000	usd
CY2021Q4	curr	Less Investor Note Offset LessInvestorNoteOffset	-5000000	usd
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	9984000	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	40000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	40000	usd
CY2022Q3	curr	Accounts Payable Factoring AccountsPayableFactoring	14000	usd
CY2021Q4	curr	Accounts Payable Factoring AccountsPayableFactoring	1722000	usd
CY2022Q3	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	5000	usd
CY2021Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	445000	usd
CY2022Q3	curr	Accrued Interest AccruedInterest	222000	usd
CY2021Q4	curr	Accrued Interest AccruedInterest	390000	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	0	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	178000	usd
CY2022Q3	us-gaap	Accrued Vacation Current And Noncurrent AccruedVacationCurrentAndNoncurrent	60000	usd
CY2021Q4	us-gaap	Accrued Vacation Current And Noncurrent AccruedVacationCurrentAndNoncurrent	173000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	813000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	243000	usd
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	317000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	334000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1431000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3485000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	9932000	usd
CY2022Q3	curr	Less Current Portion Of Convertible Promissory Notes At Fair Value LessCurrentPortionOfConvertiblePromissoryNotesAtFairValue	-9984000	usd
CY2021Q4	curr	Less Current Portion Of Convertible Promissory Notes At Fair Value LessCurrentPortionOfConvertiblePromissoryNotesAtFairValue	-9932000	usd
CY2022Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2022Q3	curr	Loans Payables Current LoansPayablesCurrent	-38000	usd
CY2021Q4	curr	Loans Payables Current LoansPayablesCurrent	-235000	usd
CY2022Q3	curr	Loans Payable Non Current LoansPayableNonCurrent	0	usd
CY2021Q4	curr	Loans Payable Non Current LoansPayableNonCurrent	0	usd
CY2022Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	3000.000	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	6000.000	usd
CY2021Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1000.000	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	3000.000	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	0	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	2877000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	100000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	100000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	200000	usd
CY2021Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	100000	usd
CY2022Q3	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2021Q4	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	550000	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	550000	usd
	curr	Scheduleoffair Value Of Convertible Promissory Notes Tabletextblock ScheduleoffairValueOfConvertiblePromissoryNotesTabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series A subordinated convertible note at fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,136</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,074</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series B subordinated convertible note at fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,848</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,858</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Total convertible promissory notes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,984</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,932</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: Investor Note offset – Series B Note</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(5,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(5,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Carrying value of convertible promissory notes at fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9,984</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9,932</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Less: current portion of convertible promissory notes at fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(9,984 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(9,932 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Convertible promissory notes, less current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q3	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	3136000	usd
CY2021Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	3074000	usd
CY2022Q3	us-gaap	Convertible Subordinated Debt ConvertibleSubordinatedDebt	11848000	usd
	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.18	pure
	us-gaap	Debt Conversion Description DebtConversionDescription	The Investor will not have the right to convert any portion of the Convertible Notes, to the extent that, after giving effect to such conversion, the Investor (and other certain related parties) would beneficially own in excess of 4.99% of the shares of Common Stock outstanding immediately after giving effect to such conversion. This limit may, from time to time, be increased, up to 9.99%, or decreased
	curr	Warrant Exercisable Shares WarrantExercisableShares	363636	shares
	curr	Description Of Debt Settlement DescriptionOfDebtSettlement	If the Company is required to settle the Series A and B Notes under those terms, the settlement would be either a cash payment of approximately $4.4 million or the issuance of 12,519,597 shares of the Company’s common stock at the option of the Investor
CY2022Q3	curr	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Bc ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBC	615530	shares
CY2021	curr	Weighted Average Remaining Contractual Life Years WeightedAverageRemainingContractualLifeYears	P0Y9M
	curr	Number Of Warrants Exercisable Weighted Average Exercise Price NumberOfWarrantsExercisableWeightedAverageExercisePrice	1.99
	curr	Number Of Warrants Exercisable NumberOfWarrantsExercisable	615530	usd
	curr	Weighted Average Exercise Price WeightedAverageExercisePrice	1.99
CY2021Q4	curr	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Bc ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBC	1565447	shares
CY2021	curr	Weighted Average Exercise Price WeightedAverageExercisePrice	2.18
CY2021	curr	Number Of Warrants Exercisable NumberOfWarrantsExercisable	1565447	usd
	curr	Weighted Average Remaining Contractual Life Years WeightedAverageRemainingContractualLifeYears	P0Y7M28D
CY2021	curr	Number Of Warrants Exercisable Weighted Average Exercise Price NumberOfWarrantsExercisableWeightedAverageExercisePrice	2.18
CY2022Q3	curr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding And Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstandingAndExercisable	0	usd
CY2021Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	68201900	shares
CY2021Q4	curr	Right Of Use Lease Liabilities Current RightOfUseLeaseLiabilitiesCurrent	104000	usd
CY2022Q3	curr	Right Of Use Lease Liability Noncurrent RightOfUseLeaseLiabilityNoncurrent	81000	usd
CY2021Q4	curr	Right Of Use Lease Liability Noncurrent RightOfUseLeaseLiabilityNoncurrent	174000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	199000	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	278000	usd
CY2022Q3	curr	Share Based Compensation Arrangement By Share Based Payment Award Options Outstand And Exercisableing Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandAndExercisableingIntrinsicValue	0	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	1100000	usd
CY2022Q3	curr	Compensation Expense To Restricted Shares CompensationExpenseToRestrictedShares	200000	usd
CY2021Q3	curr	Compensation Expense To Restricted Shares CompensationExpenseToRestrictedShares	900000	usd
	curr	Compensation Expense To Restricted Shares CompensationExpenseToRestrictedShares	500000	usd
	curr	Compensation Expense To Restricted Shares CompensationExpenseToRestrictedShares	1200000	usd
	curr	Schedule Of Nonvested Restricted Award Shares ScheduleOfNonvestedRestrictedAwardShares	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Restricted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stock Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Grant Date</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Non-vested, December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.60</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">338,443</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(338,443 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.26</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Forfeited/Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Non-vested, December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"/><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">921,664</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.31</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(921,664 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.31</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Forfeited/Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Non-vested, September 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"/><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	71376799	shares
CY2020Q4	curr	Payment Of Upfront Payment In Cash PaymentOfUpfrontPaymentInCash	1000000.0	usd
	curr	Closing Merger Consideration Shares ClosingMergerConsiderationShares	6909091	shares
	curr	Contingent Consideration Shares Clawback Shares ContingentConsiderationSharesClawbackShares	5988024	shares
CY2020Q4	curr	Potential Shares To Be Issued During Period PotentialSharesToBeIssuedDuringPeriod	5988024	shares
CY2020Q4	curr	Business Combination Contingent Shares Fair Value Amount BusinessCombinationContingentSharesFairValueAmount	3200000	usd
CY2021	curr	Fair Value Of Contingent Share Consideration Assets Fair Value FairValueOfContingentShareConsiderationAssetsFairValue	1430000	usd
	curr	Fair Value Contingent Share Consideration Assets Fair Value Disclosure Amount FairValueContingentShareConsiderationAssetsFairValueDisclosureAmount	917000	usd
	curr	Fair Value Contingent Share Consideration Fair Value Net Change In Fair Value Amount FairValueContingentShareConsiderationFairValueNetChangeInFairValueAmount	-513000	usd
	curr	Weighted Average Discount Rate In Percentage WeightedAverageDiscountRateInPercentage	0.1130	pure
	curr	Schedule Of Future Lease Paymentstabletextblock ScheduleOfFutureLeasePaymentstabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Years</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:11.25pt">2022 (remaining)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">33</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:11.25pt">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">138</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:11.25pt">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">46</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Undiscounted cash flow</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">217</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Effects of discounting</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(18 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lease liabilities recognized</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">199</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q3	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	33000	usd
CY2022Q3	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	138000	usd
CY2022Q3	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	46000	usd
CY2022Q3	curr	Lessor Operating Lease Payments Undiscounted Cash Flow LessorOperatingLeasePaymentsUndiscountedCashFlow	217000	usd
CY2022Q3	us-gaap	Other Commitment OtherCommitment	18000	usd
CY2022Q3	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	199000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	186000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	257000	usd
CY2022Q3	curr	Right Of Use Lease Liabilities Current RightOfUseLeaseLiabilitiesCurrent	118000	usd
	curr	Weighted Average Remaining Lease Term Operating Lease WeightedAverageRemainingLeaseTermOperatingLease	P1Y6M29D
CY2021	curr	Weighted Average Remaining Lease Term Operating Lease WeightedAverageRemainingLeaseTermOperatingLease	P2Y3M14D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1130	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1130	pure

Files In Submission

Name	View Source	Status
0001477932-22-008821-index-headers.html	Edgar Link	pending
0001477932-22-008821-index.html	Edgar Link	pending
0001477932-22-008821.txt	Edgar Link	pending
0001477932-22-008821-xbrl.zip	Edgar Link	pending
curr-20220930.xsd	Edgar Link	pending
curr_10q.htm	Edgar Link	pending
curr-20220930_cal.xml	Edgar Link	unprocessable
curr-20220930_def.xml	Edgar Link	unprocessable
curr-20220930_lab.xml	Edgar Link	unprocessable
curr-20220930_pre.xml	Edgar Link	unprocessable
curr_ex311.htm	Edgar Link	pending
curr_ex312.htm	Edgar Link	pending
curr_ex321.htm	Edgar Link	pending
curr_ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
curr_10q_htm.xml	Edgar Link	completed
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVRW
Avenir Wellness Solutions, Inc. Stock $avrw

2022 Q4 Form 10-Q Financial Statement

#000147793222008821 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVRW Avenir Wellness Solutions, Inc. Stock $avrw

2022 Q4 Form 10-Q Financial Statement

#000147793222008821 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVRW
Avenir Wellness Solutions, Inc. Stock $avrw